Literature DB >> 2395088

HLA antigen frequencies in HIV-1-related Kaposi's sarcoma.

D L Mann1, C Murray, M O'Donnell, W A Blattner, J J Goedert.   

Abstract

In an ongoing study of genetic factors that might contribute to disease outcome in HIV-1-infected individuals, HLA antigen (A, B, C, DR and DQ) frequencies in 44 patients with Kaposi's sarcoma (KS) and/or 14 with KS and opportunistic infection (OI) were compared with the frequencies found in 83 HIV-1-seropositive (disease-free) and 87 seronegative homosexual men, or with 50 patients with OI. KS patients had higher frequencies of HLA-B35, -C4, -DR1, and -DQ1 and lower frequencies of HLA-C5 and -DR3 compared to the total control population (N = 170) and to the population at risk (HIV-1-seropositive, disease-free). HLA-DR5, reported by others to be increased in frequency in classical KS as well as HIV-1-related KS, was not found to be increased in the KS cohort. Antigen frequencies in the patients with KS differed from the frequencies in patients with OI by an increase in HLA-A23, -C4, -DR14, and -DR53. These results suggest that genetic factors controlled by the human major histocompatibility complex (MHC) may influence disease outcome in HIV-1-infected homosexual men.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395088

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  9 in total

Review 1.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

2.  Role of the HLA System in the Pathogenesis of Dupuytren's Disease.

Authors:  Sara McCarty; Farhatullah Syed; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2010-02-09

3.  Maternal human leukocyte antigen A*2301 is associated with increased mother-to-child HIV-1 transmission.

Authors:  Romel D Mackelprang; Mary Carrington; Grace John-Stewart; Barbara Lohman-Payne; Barbra A Richardson; Dalton Wamalwa; Xiaojiang Gao; Maxwel Majiwa; Dorothy Mbori-Ngacha; Carey Farquhar
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

4.  Fifty-one Kaposi sarcoma patients.

Authors:  Mutlu Dogan; Lutfi Dogan; Feyyaz Ozdemir; Nuriye Yildirim Ozdemir; Hasan Senol Coskun; Ulku Yalcintas Arslan; Guze Ozal; Gungor Utkan; Ahmet Demirkazik; Fazil Aydin; Nurullah Zengin; Fikri Icli
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

5.  Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.

Authors:  R Reshef; M R Luskin; M Kamoun; S Vardhanabhuti; J E Tomaszewski; E A Stadtmauer; D L Porter; D F Heitjan; De E Tsai
Journal:  Am J Transplant       Date:  2011-03-14       Impact factor: 8.086

Review 6.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

7.  Biological individuality and disease. From Garrod's Chemical Individuality to HLA associated diseases.

Authors:  G R Burgio
Journal:  Acta Biotheor       Date:  1993-09       Impact factor: 1.774

8.  Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.

Authors:  Romel D Mackelprang; Mary Carrington; Katherine K Thomas; James P Hughes; Jared M Baeten; Anna Wald; Carey Farquhar; Kenneth Fife; Mary S Campbell; Saida Kapiga; Xiaojiang Gao; James I Mullins; Jairam R Lingappa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

9.  SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi's sarcoma.

Authors:  B Aissani; A K Boehme; H W Wiener; S Shrestha; L P Jacobson; R A Kaslow
Journal:  Genes Immun       Date:  2014-07-10       Impact factor: 2.676

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.